Data partnerships Akrivia Health curates the world’s most in-depth neuropsychiatric and neurodegenerative dataset by linking structured and unstructured EHRs with genomic and longitudinal insights, presenting a strong opportunity to offer data integration, curation, and analytics solutions to researchers, pharma, and healthcare providers seeking faster access to higher quality data.

AI enabled NLP Their AI-enabled solutions use advanced NLP to extract deep phenotypic signals from clinical notes for patient stratification and real-world evidence generation, signaling potential to upsell advanced analytics platforms, NLP model customization, and real-time data extraction services.

Clinical trial optimization The capability to evaluate treatment effectiveness and optimize clinical trials positions opportunities for collaboration with CROs, biotech and pharma companies seeking faster, more precise trial design, patient recruitment, and outcome tracking in mental health and dementia programs.

Funding and scale With current revenue in the low millions and notable funding, Akrivia Health is in growth mode, suggesting readiness for strategic partnerships, larger pilot programs, and additional investment in data infrastructure, regulatory readiness, and commercial expansion.

Regional focus Based in Oxford, UK, the company can leverage proximity to European research ecosystems and NHS/Oxford University networks for partnerships, pilot studies, and access to academic collaborations, while also exploring global data partnerships to extend their dataset.